Recombinant mycobacterial proteins future directions to improve protective efficacy

Indian Journal of Experimental Biology

Volumn 39, Issue 12, 2001, Pages 1214-1219

  Sharma, A K ^a   Khuller, G K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; IMMUNOLOGY; VACCINES;

PROTECTIVE EFFICACY;

PROTEINS;

BACTERIAL PROTEIN; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; MYCOBACTERIUM; PROTEIN PROCESSING; REVIEW; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; HUMANS; MICE; MYCOBACTERIUM; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; SPECIES SPECIFICITY;

EID: 0035543652     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Protective effect of BCG in experimental tuberculosis
2. Efficacy of BCG vaccine in the prevention of tuberculosis. Metaanalysis of the published literature
3. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis
4. Novel insights into the genetics, biochemistry & immunocytochemistry of the 30kDa major extracellular protein of Mycobacterium tuberculosis
5. Coimmunization with DNA vaccines expressing granulocyte macrophage colony stimulating factor & mycobacterial secreted proteins enhances T cell immunity, but not protective efficacy against Mycobacterium tuberculosis
6. Immunization with extracellular proteins of Mycobacterium tuberculosis induced cell mediated immune responses & substantial protective immunity in a guinea pig model of pulmonary tuberculosis
7. Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances γinterferon production by splenocytes
8. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis
9. 37Ra
10. 37Rv & its protective efficacy against experimental tuberculosis
11. Evaluation of the T cell and costimulatory molecules in the protective efficacy of 30kDa secretory protein against experimental tuberculosis
12. Towards development of T cell vaccines
13. Immunogenicity & protective efficacy of a tuberculosis DNA vaccine
14. Evaluations of new vaccines in the mouse & guinea pig model of tuberculosis
15. Immunogenicity of DNA vaccines expressing tuberculosis proteins fixed on tissue plasminogen activator signal sequences
16. DNA vaccination against tuberculosis: Expression of a ubiquitin conjugated tuberculosis protein enhances antimycobacterial immunity
17. Mycobacterial protein antigens: A compilation
18. Biochemical & antigenic characterization of Mycobacterium tuberculosis 71kD antigen, a member of 70kD heat shock protein family
19. Characterization, sequence determination & immunogenicity of a 64 kilodalton protein of Mycobacteriurn bovis BCG expressed in E. coli K-12
20. Identification of T cell stimulatory peptides from the 38 kDa protein of Mycobacterium tuberculosis
21. Cloning & expression of the gene for the cross reactive alpha antigen of Mycobacterium kanasasii
22. Murine T cell stimulatory peptides from the 19kDa antigen of Mycobacterium tuberculosis: Epitope restricted homology with the 28kDa protein of Mycobacterium leprae
23. Identification, isolation & partial characterization of Mycobacterium tuberculosis glycoproteins antigens
24. Purification & characterization of major antigens from a Mycobacterium bovis culture filtrate
25. Lipoprotein antigens of Mycobacterium tuberculosis
26. Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model
27. Coexpression of interleuin-2 & green fluorescent reporter protein in mycobacteria: In vivo application for monitoring antimycobacterial immunity
28. New tuberculosis vaccines based on attenuated strains of the Mycobacterium tuberculosis complex
29. A proposed mechanism for the induction of cytotoxic T lymphocyte production by heat shock fusion proteins
30. Extracytoplasmic proteins of Mycobacterium tuberculosis mature secreted proteins often start with aspartic acid & proline
31. Molecular cloning, purification & serological characterization of MPT 63, a novel antigen secreted by Mycobacterium tuberculosis
32. Identification, sequencing & expression of Mycobacterium leprae superoxide dismutase, a major antigen
33. Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis
34. Vaccination with recombinant vaccinia viruses protects mice against Mycobacterium tuberculosis infection
35. Systemic and mucosal immunity induced by BCG vector expressing outersurface protein A of Borrelia burgdorferi
36. Immunogenicity & protection studies with recombinant mycobacteria & vaccinia vectors coexpressing the 18kDa protein of Mycoabcterium leprae
37. Vaccination with recombinant vaccinia viruses protects mice against Mycobacterium tuberculosis infection
38. Vaccines against tuberculosis
39. Expression of Mycobacterium leprae proteins by vaccinia virus
40. The 19kD antigen and protective immunity in a murine model of tuberculosis
41. Cloning & expression of Mycobacterium bovis BCG gene for extracellular alpha antigen
42. Analysis of posttranslational modification of mycobacterial proteins using a cassette expressing system
43. Expression of the Mycobacterium tuberculosis 19 kDa antigens in Mycobacterium smegmatis. Immunological analysis & evidence of glycosylation